Assessment of Drug Safety Governance in Guyana: Insights from Published Research

Developing countries like Guyana face unique challenges in ensuring drug supply safety due to limited resources, weak regulatory systems, and inadequate surveillance infrastructure.This paper presents a literature-based evaluation of drug safety oversight in Guyana.The evaluation identifies significant gaps and challenges within Guyana's regulatory agencies, including resource constraints, insufficient surveillance infrastructure, and enforcement weaknesses.Limited specific literature on Guyana highlights the need for empirical studies to assess the effectiveness of its drug regulatory systems.Through a systematic literature review, this study identifies key areas for improving drug safety oversight, emphasizing enhanced resource allocation, capacity-building initiatives, and robust regulatory frameworks.These findings emphasize the importance of strengthening regulatory systems in developing countries to ensure public health and access to safe pharmaceuticals.This evaluation offers insights for policymakers, healthcare professionals, and stakeholders involved in public health governance, facilitating evidence-based strategies to enhance drug safety oversight and regulatory effectiveness in Guyana.